1. Home
  2. RYOJ vs CCEL Comparison

RYOJ vs CCEL Comparison

Compare RYOJ & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYOJ

rYojbaba Co. Ltd. Common Shares

N/A

Current Price

$4.03

Market Cap

42.8M

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$3.99

Market Cap

35.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RYOJ
CCEL
Founded
2015
1989
Country
Japan
United States
Employees
N/A
N/A
Industry
Professional Services
Managed Health Care
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.8M
35.8M
IPO Year
2025
1997

Fundamental Metrics

Financial Performance
Metric
RYOJ
CCEL
Price
$4.03
$3.99
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
71.7K
3.8K
Earning Date
12-19-2025
10-15-2025
Dividend Yield
N/A
10.03%
EPS Growth
72.91
N/A
EPS
0.13
N/A
Revenue
$11,576,848.00
$31,747,500.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
$30.25
N/A
Revenue Growth
5.60
N/A
52 Week Low
$1.81
$3.57
52 Week High
$11.43
$8.86

Technical Indicators

Market Signals
Indicator
RYOJ
CCEL
Relative Strength Index (RSI) N/A 45.97
Support Level N/A $4.04
Resistance Level N/A $4.08
Average True Range (ATR) 0.00 0.18
MACD 0.00 -0.01
Stochastic Oscillator 0.00 47.95

Price Performance

Historical Comparison
RYOJ
CCEL

About RYOJ rYojbaba Co. Ltd. Common Shares

rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: